Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Return on Sales (2016 - 2025)

Veracyte's Return on Sales history spans 14 years, with the latest figure at 0.29% for Q4 2025.

  • For Q4 2025, Return on Sales rose 25.0% year-over-year to 0.29%; the TTM value through Dec 2025 reached 0.13%, up 7.0%, while the annual FY2025 figure was 0.13%, 7.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.29% at Veracyte, up from 0.15% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.29% in Q4 2025 and bottomed at 1.14% in Q1 2021.
  • The 5-year median for Return on Sales is 0.1% (2023), against an average of 0.12%.
  • The largest annual shift saw Return on Sales plummeted -76bps in 2021 before it skyrocketed 93bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 0.16% in 2021, then soared by 69bps to 0.05% in 2022, then plummeted by -499bps to 0.29% in 2023, then surged by 115bps to 0.04% in 2024, then surged by 582bps to 0.29% in 2025.
  • Per Business Quant, the three most recent readings for VCYT's Return on Sales are 0.29% (Q4 2025), 0.15% (Q3 2025), and 0.01% (Q2 2025).